NPAT down 37% on a tax spike as PBT fell 19% despite 4.7% revenue growth

What changed

Revenue rose 4.7% to $56.1m, but profitability weakened at every line below. Operating profit fell 8.6% to $16.3m, profit before tax dropped 18.7% to $13.4m, and reported NPAT fell 37.0% to $7.4m. The NPAT decline was amplified by a sharp rise in the effective tax rate to 45.1% from 29.1%, so PBT (-18.7%) is the cleaner operating read.

Operating cash flow fell 22.3% to $12.8m while capex eased to $10.3m from $14.4m, producing pre-lease free cash flow of $2.5m (prior $2.1m). Gross borrowings rose to $35.8m from $30.0m, lifting net debt to approximately $33.4m from $29.0m. The final dividend was held flat at 19.5c (full-year dividend 27.0c), and the board disclosed a normalised NPAT of $9.96m versus $11.50m prior.

What matters

• Tax-driven NPAT shock vs genuine operating deterioration. The PBT-to-NPAT divergence (18.3pp gap) is tax-line driven rather than a discontinued operation, but PBT itself still fell 18.7% on higher revenue, meaning margins compressed meaningfully at the operating level.
• Dividend cover has broken at the FCF line. Payout on statutory NPAT rose to 69.4% from 43.7%, and pre-lease FCF of $2.5m covers only ~49% of the cash dividend (payout ratio vs FCF ~205%). The shortfall coincides with gross borrowings rising $5.8m, so the held-flat dividend is effectively being funded via the balance sheet.
• Leverage direction is weakening. Net debt rose ~15% while equity was broadly flat ($60.2m), and ROE fell to 12.2% from 19.6%. With no EBITDA disclosure, a net-debt-to-EBITDA gearing ratio cannot be computed from the filing.

Expectations

No quantified forward guidance, forward work backlog, or stated target was provided. The only forward anchor is qualitative: management cites the NZAS agreement as stabilising roughly one-third of cargo volume, consistent with disclosed customer concentration.

Seasonality context shows HY24 contributed 45.4% of full-year revenue and only 41.1% of full-year NPAT, indicating a second-half-weighted profit pattern. The implied H2 NPAT of $4.3m was a clear step up on the $3.0m first half but was not enough to close the gap to FY23. The release does not support any inference about FY25 earnings trajectory beyond the NZAS stability commentary.

Quality of result

The result is mixed on quality. Positives: revenue growth was achieved, the company disclosed a normalised NPAT of $9.96m that implies ~$2.6m of one-off drag (though no item-level reconciliation was provided), and capex was lower than prior year.

Negatives are more material:

• Operating cash flow fell faster than revenue grew, and receivable days stretched to ~53 from ~44, indicating cash conversion deteriorated materially in the year.
• The held-flat dividend was funded partly by $5.75m of additional borrowings, not by operating cash generation.
• Without a reconciliation of the $2.58m normalisation adjustment, the $9.96m "excluding one-offs" figure cannot be independently validated.

The step-down in ROE from 19.6% to 12.2% on broadly flat equity reinforces that the earnings weakness is operational, not purely a tax accident.

Unresolved

• What drove the effective tax rate to 45.1%, and is any portion recurring into FY25?
• What are the specific items inside the $2.58m normalisation bridge between statutory NPAT ($7.4m) and normalised NPAT ($10.0m)?
• Why did operating cash flow fall 22% on revenue growth of 5% — is the receivables build a timing issue at 30 June or a structural collection slowdown?
• What is the board's medium-term view on sustaining a 27.0c dividend given pre-lease FCF of only $2.5m and rising net debt?
• What is management's expected capex profile from here, given FY24 capex of $10.3m followed $14.4m in FY23?

This briefing cannot assess the underlying commodity volume mix, the specific terms and duration of the NZAS agreement, or any EBITDA-based leverage metric, as those disclosures were not provided in the supplied excerpts.

Key metrics

Analytical metrics

---

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.